Biennial screening mammography is cost effective in healthy women aged over 65 years - 24/08/11
Abstract |
Question |
What is the cost-effectiveness of screening mammography in women over 65 years old?
Study design |
Systematic review with narrative synthesis.
Main results |
Ten studies, out of 115 identified, met inclusion criteria. Studies had similar cost-effectiveness findings; extending biennial screening to ages 75–80 years cost, on average, $34,000–$88,000 per life year gained compared with stopping screening at age 65 (adjusted to 2002 US dollars). Two studies found breast cancer screening less effective at reducing mortality in women with significant comorbidities (dementia, congestive heart failure, or hypertension), thus reducing the cost-effectiveness of screening in this population. No study fully adjusted for potential harms of screening.
Authors’ conclusions |
In women aged over 65 years without serious comorbidity, biennial breast cancer screening reduces mortality at reasonable costs.
Le texte complet de cet article est disponible en PDF.Keywords : Breast cancer, Mass screening, Mammography, Cost-effectiveness, Elderly, Systematic review
Plan
 | Abstracted from: Mandelblatt J, Saha S, Teutsch S, et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2003; 139: 835–842. |
Vol 8 - N° 3
P. 142-144 - juin 2004 Retour au numéro
Article précédent
- Survival of people with out-of-hospital cardiac arrest is not improved by equipping first responders with an automated external defibrillator
- Judith Finn, Ian Jacobs
- Breast-feeding has little effect on blood pressure in later life
- Undurti N Das
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?